Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
Biocept (BIOC) - Cash on Hand
Cash on Hand as of June 2023 : $6.63 M
According to Biocept
's latest financial reports the company has $6.63 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Biocept - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $12.89 M | -55.32% |
| 2021-12-31 | $28.86 M | 100.89% |
| 2020-12-31 | $14.36 M | 54.47% |
| 2019-12-31 | $9.3 M | 171.7% |
| 2018-12-31 | $3.42 M | 59.48% |
| 2017-12-31 | $2.14 M | -53.43% |
| 2016-12-31 | $4.6 M | -47.75% |
| 2015-12-31 | $8.82 M | 64.44% |
| 2014-12-31 | $5.36 M | 7654.75% |
| 2013-12-31 | $0.06 M | -62.66% |
| 2012-12-31 | $0.18 M | -57.44% |
| 2011-12-31 | $0.43 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | $0.21 B | 3,163.29% | 🇺🇸 USA |
 Exact Sciences EXAS | $0.77 B | 11,623.87% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.14 B | 2,024.23% | 🇺🇸 USA |